Treatment of perforated acute cholecystitis with percutaneous cholecystostomy

Acute cholecystitis is a common disease treated with laparoscopic cholecystectomy as a standard procedure. Perforated cholecystitis is a complication of acute cholecystitis and patients with comorbidities who have a high risk for the operation may also be treated with percutaneous cholecystostomy. T...

Full description

Bibliographic Details
Main Author: Sevcan Alkan Kayaoglu
Format: Article
Language:English
Published: Society of Turaz Bilim 2022-03-01
Series:Medicine Science
Subjects:
Online Access:http://www.ejmanager.com/fulltextpdf.php?mno=96887
_version_ 1797328203290771456
author Sevcan Alkan Kayaoglu
author_facet Sevcan Alkan Kayaoglu
author_sort Sevcan Alkan Kayaoglu
collection DOAJ
description Acute cholecystitis is a common disease treated with laparoscopic cholecystectomy as a standard procedure. Perforated cholecystitis is a complication of acute cholecystitis and patients with comorbidities who have a high risk for the operation may also be treated with percutaneous cholecystostomy. The procedure may also be applied for the selected patients with perforated cholecystitis who have a delayed admission to the health institution or who are irresponsive to antibiotherapy. The aim of the present study is to investigate the clinical outcomes and data of the acute cholecystitis patients who underwent percutaneous cholecystostomy. Twentyfour patients who underwent percutaneous cholecystostomy with the diagnosis of perforated acute calculous cholecystitis between October 2012 and February 2020 were included in the study. Diagnosis of acute cholecystitis was made based on the Tokyo Criteria. Patient data were reached through a retrospective screening. Of the total of 24 patients, 70.8% were males. Mean age was 63.3±12.9 years and mean duration of hospital stay was 13.0±9.4 days. All patients were grade 2 according to Tokyo 2018 severity stratification. Mean duration of catheter stay was 37.7±25.3 days. Fifteen patients (62.5%) underwent cholecystectomy. Ratio of complications was 16.7% and catheter dislocation (n=2) was the most common complication. Mean duration of follow-up was 1 year. No patients developed acute cholecystitis on follow-ups, one patient developed acute cholangitis. Mortality rate was calculated for 60 days and no mortality was detected. High risk patients with comorbid conditions may be safely treated with percutaneous cholecystostomy as perforated cholecystitis increases mortality and morbidity in patients with acute cholecystitis. [Med-Science 2022; 11(1.000): 176-9]
first_indexed 2024-03-08T06:47:28Z
format Article
id doaj.art-c07926c70a48410a83f66a8b9413a7a9
institution Directory Open Access Journal
issn 2147-0634
language English
last_indexed 2024-03-08T06:47:28Z
publishDate 2022-03-01
publisher Society of Turaz Bilim
record_format Article
series Medicine Science
spelling doaj.art-c07926c70a48410a83f66a8b9413a7a92024-02-03T07:29:09ZengSociety of Turaz BilimMedicine Science2147-06342022-03-01111176910.5455/medscience.2021.07.23396887Treatment of perforated acute cholecystitis with percutaneous cholecystostomySevcan Alkan Kayaoglu0Department of General Surgery, Haydarpasa Numune Training and Research Hospital, Istanbul, TurkeyAcute cholecystitis is a common disease treated with laparoscopic cholecystectomy as a standard procedure. Perforated cholecystitis is a complication of acute cholecystitis and patients with comorbidities who have a high risk for the operation may also be treated with percutaneous cholecystostomy. The procedure may also be applied for the selected patients with perforated cholecystitis who have a delayed admission to the health institution or who are irresponsive to antibiotherapy. The aim of the present study is to investigate the clinical outcomes and data of the acute cholecystitis patients who underwent percutaneous cholecystostomy. Twentyfour patients who underwent percutaneous cholecystostomy with the diagnosis of perforated acute calculous cholecystitis between October 2012 and February 2020 were included in the study. Diagnosis of acute cholecystitis was made based on the Tokyo Criteria. Patient data were reached through a retrospective screening. Of the total of 24 patients, 70.8% were males. Mean age was 63.3±12.9 years and mean duration of hospital stay was 13.0±9.4 days. All patients were grade 2 according to Tokyo 2018 severity stratification. Mean duration of catheter stay was 37.7±25.3 days. Fifteen patients (62.5%) underwent cholecystectomy. Ratio of complications was 16.7% and catheter dislocation (n=2) was the most common complication. Mean duration of follow-up was 1 year. No patients developed acute cholecystitis on follow-ups, one patient developed acute cholangitis. Mortality rate was calculated for 60 days and no mortality was detected. High risk patients with comorbid conditions may be safely treated with percutaneous cholecystostomy as perforated cholecystitis increases mortality and morbidity in patients with acute cholecystitis. [Med-Science 2022; 11(1.000): 176-9]http://www.ejmanager.com/fulltextpdf.php?mno=96887percutaneous cholecystostomyperforationacute cholecystitis
spellingShingle Sevcan Alkan Kayaoglu
Treatment of perforated acute cholecystitis with percutaneous cholecystostomy
Medicine Science
percutaneous cholecystostomy
perforation
acute cholecystitis
title Treatment of perforated acute cholecystitis with percutaneous cholecystostomy
title_full Treatment of perforated acute cholecystitis with percutaneous cholecystostomy
title_fullStr Treatment of perforated acute cholecystitis with percutaneous cholecystostomy
title_full_unstemmed Treatment of perforated acute cholecystitis with percutaneous cholecystostomy
title_short Treatment of perforated acute cholecystitis with percutaneous cholecystostomy
title_sort treatment of perforated acute cholecystitis with percutaneous cholecystostomy
topic percutaneous cholecystostomy
perforation
acute cholecystitis
url http://www.ejmanager.com/fulltextpdf.php?mno=96887
work_keys_str_mv AT sevcanalkankayaoglu treatmentofperforatedacutecholecystitiswithpercutaneouscholecystostomy